Federal Reports

The Nation has been grappling with an opioid crisis for several years. In 2017 alone, there were 47,600 opioid-related overdose deaths in the United States. It continues to be a public health emergency. OIG has been tracking opioid use in Medicare during this crisis, particularly since 2016. OIG has identified beneficiaries at serious risk of misuse or overdose and has identified prescribers with questionable prescribing for these beneficiaries. These types of analyses are crucial to understanding and addressing the national opioid crisis. Building on past OIG work, this data brief details opioid use in Medicare Part D in 2018 and trends in drugs used to treat opioid use disorder.

The unclassified version of the SAR covers the period from October 1, 2018 through March 31, 2019, and reflects what NSA OIG could release publicly about its work for that reporting period. The OIG issued 13 reports and oversight memoranda during that period, making 198 recommendations to assist the Agency in addressing the findings and deficiencies identified. NSA's management agreed with all OIG recommendations made during this period. The Director of the NSA and Congress previously received the classified version of the SAR in accordance with the IG Act.

In accordance with our Annual Performance Plan Fiscal Year 2019, the Office of Inspector General (OIG) conducted a performance audit of the United States Capitol Police (USCP or the Department) Records Management Program. OIG objectives were to determine if the Department (1) established adequate policies and procedures for its Records Management Program, (2) established effective controls for ensuring the integrity of the Records Management Program, and (3) complied with applicable laws, regulations, and guidance. Our scope included controls, processes, and operations during calendar year 20I8.

An Amtrak employee in Chicago, Illinois, resigned from employment on July 5, 2019, following our investigation, which revealed the employee violated company policies by engaging in outside employment while taking leave from the company under the Family Medical Leave Act (FMLA). During an interview, the employee admitted that he worked at his private business while on FMLA leave. The employee resigned from Amtrak prior to his disciplinary hearing.